GE launches innovative technology in Indian medical device market

Posted by sushmita sengupta On May - 22 - 2013

GE Healthcare has very recently launched its 1st healthcare technology experiential lounge on wheels under its Mission Healthier India in Coimbatore. The entire set up has been built at a cost of INR 4 mn that comprises of equipment such as ECG, scan, critical tools and infant care technologies. The mission was focused at upliftment [...]

Indian healthcare market gets its 1st ever indigenous rotavirus vaccine

Posted by sushmita sengupta On May - 15 - 2013

Indian healthcare industry will very soon launch its 1st completely indigenous and affordable rotavirus diarrhoea vaccine that took almost 28 years of hard work. The results of the Phase III clinical trial of the Rotavac vaccine was announced at an international conference that declared efficiency level at 56% in the 1st year of life. The [...]

Transportation & logistics market to see more divestment by Gati

Posted by Ankita Palit On May - 14 - 2013

Gati Ltd, one of leading player in the transportation & logistics market has sold 40% of its stake in Gati Ship to Riba Constructions. The deal was worth INR 80 mn which is expected to be complete by June 2013. The express distribution and supply chain solutions provider has plans to divest further in the [...]

Biocon and Trinity collaborate to encourage genetic research

Posted by sushmita sengupta On May - 14 - 2013

Bengaluru based Biocon has entered into a partnership with Dublin-based Trinity College to support Indian students in genetic research. Biocon will sponsor two annual sponsorships that would give meritorious candidates an opportunity to work in Trinty College laboratories. The sponsorship program has been especially designed to encourage innovation in the field of biotechnology. The sponsorship [...]

Dubai based Jumeirah Group planning hotel in Goa

Posted by George Mathew On May - 13 - 2013

Even as its first hotel in India is set to debut in Mumbai in 2017, Dubai based hotel chain Jumeirah Group is planning a new venture in Goa. The hotel group is in discussions with the developer of the Mumbai property to develop another hotel in Goa. The company has been looking to make its [...]

Research On India Blog

Glenmark’s drug Revamilast to enter phase III clinical trial soon

Posted by sushmita.sengupta On May - 25 - 2012

Mumbai based Glenmark Pharmaceuticals inflammatory disorder treatment drug Revamilast will enter the 3rd phase of clinical trial inUSA,UK andIndia very soon. The drug is targeted for the relief of disorders like asthma and rheumatoid arthritis. The molecule had successfully completed its pre clinical and phase I trials that had been conducted inBritain and is expecting Phase-IIb data in rheumatoid arthritis by March 2013 and clinical trial data for asthma by the middle of 2013.

Glenmark also plans to file an Investigational New Drug application (IND) for Revamilast in USA within the 3rd quarter of FY 2012. Glenmark has invested a huge amount in R&D in the recent past for development of innovative and effective drugs.

Source: Business Standard

Healthcare, Market Insights

Leave a Reply

Presentation

Ceramic Tiles Market in India Sample
View more presentations from Research on India.

Tags

acquisition bangalore beer beverage cargo DTH Education electricity energy Entertainment expansion food government gujarat healthcare higher hospital India investment IPO Joint Venture Latest Market Research logistics media medical micro mobile mumbai MVAS nuclear online outlets pe power reliance renewable retail solar solar power stake Telecom India value VAS warehousing wind